Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 5, 2005, Pages 842-843

  Rickles, Frederick R ^a   Marder, V J ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CLINICAL TRIAL; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; PRIORITY JOURNAL; SHORT SURVEY; THROMBOEMBOLISM; THROMBOSIS; VEIN THROMBOSIS; ARTICLE; BLEEDING; METHODOLOGY; ORAL DRUG ADMINISTRATION; RETROSPECTIVE STUDY;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; RESEARCH DESIGN; RETROSPECTIVE STUDIES; WARFARIN;

EID: 23844453148     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01397.x     Document Type: Short Survey

References (7)

1. Rosove MH, Brewer PM. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303-8.
2. Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, Laskin C, Fortin P, Anderson D, Kearon C, Clarke A, Geerts W, Forgie M, Green D, Costantini L, Yacura W, Wilson S, Gent M, Kovacs MJ. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003; 349: 1133-8.
3. [Erratum in N Engl J Med 2003; 349: 2577].
4. Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D'Angelo A, Tognoni G, Barbui T. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 2005; 3: 848-53.
5. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 401S-28S.
6. Hull R, Hirsh J, Jay R, Carter C, England C, Gent M, Turpie AG, McLoughlin D, Dodd P, Thomas M, Raskob G, Ockelford P. Different intensities of oral anticoagulation therapy in the treatment of proximal-vein thrombosis. N Engl J Med 1982; 307: 1676-81.
7. Paul N, Kosinski CM, Gelber AC, Saleh AS, Stern SD, Crowther M, Ginsberg J. Warfarin prophylaxis in the antiphospholipid antibody syndrome [multiple letters]. N Engl J Med 2003; 349: 2568-70.